XML 34 R16.htm IDEA: XBRL DOCUMENT v3.24.3
STOCK-BASED COMPENSATION AND BENEFIT PLANS
 12 Months Ended
Jun. 29, 2024
Share-Based Payment Arrangement [Abstract]  
STOCK-BASED COMPENSATION AND BENEFIT PLANS STOCK-BASED COMPENSATION AND BENEFIT PLANS
The Company’s incentive plan provides for equity and liability awards to employees and non-employee directors in the form of stock options, stock appreciation rights (SARs), restricted stock, restricted stock units, stock awards, stock units, performance shares, performance units, and other stock-based or cash-based awards. Compensation cost is recognized on a straight-line basis over the requisite employee service period, which is generally the vesting period, and is recorded as employee compensation expense in cost of goods sold, research, development and engineering, and selling, general and administrative expenses. Share-based compensation is recognized only for those awards that are expected to vest, with forfeitures estimated at the date of grant based on historical experience and future expectations.
In addition to service conditions, these SARs contain a performance condition. The additional performance condition is based upon the achievement of Return on Invested Capital (ROIC) goals relative to a peer group. All awards with performance conditions are measured over the vesting period and are charged to compensation expense over the requisite service period based on the number of shares expected to vest. The SARs cliff vest after a three-year period from date of grant based on the performance metric and expire five years from date of grant.
On July 29, 2022, the Company granted 145,000 SARs under the 2010 Incentive Plan to certain key employees and outside directors at a strike price of $5.10 and a grant date fair value of $2.09. As of June 29, 2024, 136,250 remain outstanding. The grant date fair value for the awards granted during fiscal year 2023, were estimated using the Black Scholes option valuation method with the following weighted average assumptions as of July 29, 2022:
Fiscal Year 2023
 July 29, 2022
Expected dividend yield—%
Risk-free interest rate3.01%
Expected volatility48.56%
Expected life4.00
On August 9, 2021, the Company granted 165,000 SARs under the 2010 Incentive Plan to certain key employees and outside directors at a strike price of $7.17 and a grant date fair value of $2.73. As of June 29, 2024, 136,250 remain outstanding. The grant date fair value for the awards granted during fiscal year 2022, were estimated using the Black Scholes option valuation method with the following weighted average assumptions as of August 9, 2021:
Fiscal Year 2022
 August 9, 2021
Expected dividend yield—%
Risk-free interest rate0.62%
Expected volatility48.58%
Expected life4.00
The Black-Scholes option valuation model is used by the Company for estimating the fair value of SARs. Option valuation models require the input of highly subjective assumptions, particularly for the expected term and expected stock price volatility. Changes in these assumptions can materially affect the fair value estimates.
Share-based compensation expense is recognized only for those awards that are expected to vest, with forfeitures estimated at the date of grant based on the Company’s historical experience and future expectations. This forfeiture rate will be revised, if necessary, in subsequent periods if actual forfeitures differ from the amount estimated. Share-based compensation expense for fiscal years ended June 29, 2024, July 1, 2023 and July 2, 2022 was $(0.4) million, $0.3 million and $0.3 million, respectively. The fiscal year 2024 amount relates to reversal of prior expense for which performance metrics were not ultimately attained.
There were no SARs exercised during fiscal year 2024, fiscal year 2023 and fiscal year 2022.
As of June 29, 2024, total unrecognized compensation expense related to nonvested share-based compensation arrangements was approximately $0.1 million. This expense is expected to be recognized over a weighted-average period of 1.0 years.
The following table summarizes the Company’s SARs activity from July 3, 2021 through June 29, 2024: 
SARs
Available
For Grant		SARs
Outstanding		Aggregate
Intrinsic
Value (in
thousands)		Weighted
Average
Exercise
Price		Weighted
Average
Remaining
Contractual
Life (in
years)
Balances, July 3, 2021688,084 791,250 $7.15 1.9
SARs granted(165,000)165,000 $7.17 
SARs expired197,500 (197,500)$8.17 
Balances, July 2, 2022720,584 758,750 $— $6.89 2.1
SARs granted(145,000)145,000 $5.10 
SARs forfeited90,000 (90,000)$6.55 
SARs expired187,500 (187,500)$7.26 
Balances, July 1, 2023853,084 626,250 $— $6.41 2.2
SARs forfeited137,500 (137,500)$6.90 
SARs expired101,250 (101,250)$8.17 
Balances, June 29, 20241,091,834 387,500 $— $5.78 1.8
Exercisable at June 29, 2024115,000 $— $4.93 0.1

The Company has defined contribution plans available to U.S. employees who have attained age 21. Company contributions to the plans were approximately $1.3 million, $1.1 million and $0.9 million during fiscal years 2024, 2023 and 2022, respectively.